1. Home
  2. News
  3. Zhuzhou Qianjin Pharmaceutical Co., Ltd.
  4. Announcement on Outline of the Q3 2024 Performance Briefing
More Zhuzhou Qianjin Pharmaceutical Co., Ltd. news
Zhuzhou Qianjin Pharmaceutical Co., Ltd.SSE: 600479

Announcement on Outline of the Q3 2024 Performance Briefing

Nov 14, 2024 · Issued by Zhuzhou Qianjin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 14, 2024 · 4 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-outline-of-the-q3-2024-performance-briefing-12

Zhuzhou Qianjin Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhuzhou Qianjin Pharmaceutical

  • Announcement on Convening the Q3 2024 Performance BriefingNov 6, 2024
  • Announcement on Main Operating Data for Q3 2024Oct 30, 2024

Later from Zhuzhou Qianjin Pharmaceutical

  • Announcement on Abnormal Fluctuations in Stock TradingNov 23, 2024
  • Announcement on Issuing Shares and Paying Cash to Purchase Assets and Changing Individual Transaction Objects in Related Party TransactionsDec 19, 2024
  • Announcement on Obtaining Notice of Approval for Drug Supplementary ApplicationJan 21, 2025
  • Announcement on Progress in Issuing Shares and Paying Cash to Purchase Assets and Related Party TransactionsJan 25, 2025
  • Announcement on Resolution of the 11th Meeting of the 11th Board of DirectorsFeb 11, 2025
All Zhuzhou Qianjin Pharmaceutical news releases↗

Follow Zhuzhou Qianjin Pharmaceutical into a list and get an email when it puts out news.

Follow Zhuzhou Qianjin Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer